Serina Therapeutics, Inc. (SER) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $6.95M | +3.4% |
| 2024 | $6.72M | -25.0% |
| 2023 | $8.97M | +176.7% |
| 2022 | $3.24M | +2.8% |
| 2021 | $3.15M | -19.6% |
| 2020 | $3.92M | -47.3% |
| 2019 | $7.44M | -30.3% |
| 2018 | $10.67M | +10.8% |
| 2017 | $9.63M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $6.95M | +3.4% |
| 2024 | $6.72M | -25.0% |
| 2023 | $8.97M | +176.7% |
| 2022 | $3.24M | +2.8% |
| 2021 | $3.15M | -19.6% |
| 2020 | $3.92M | -47.3% |
| 2019 | $7.44M | -30.3% |
| 2018 | $10.67M | +10.8% |
| 2017 | $9.63M | — |